Similar articles

• Molecular evidence for multifocal papillary serous carcinoma of the peritoneum in patients with germline BRCA1 mutations.

  Schorge JO, Muto MG, Welch WR, Bandera CA, Rubin SC, Bell DA, Berkowitz RS, Mok SC. Schorge JO, et al. J Natl Cancer Inst. 1998 Jun 3;90(11):841-5. doi: 10.1093/jnci/90.11.841. J Natl Cancer Inst. 1998. PMID: 9625172
• Peritoneal carcinoma in women with genetic susceptibility: implications for Jewish populations.

  Casey MJ, Bewtra C. Casey MJ, et al. Fam Cancer. 2004;3(3-4):265-81. doi: 10.1007/s10689-004-9554-y. Fam Cancer. 2004. PMID: 15516851 Review.
• Is papillary serous carcinoma of the peritoneum (PSCP) a multifocal disease?

  Imura J, Fujimori T. Imura J, et al. J Gastroenterol. 2000;35(7):570-2. doi: 10.1007/s005350070084. J Gastroenterol. 2000. PMID: 10905369 No abstract available.
• Genetic alterations of the WT1 gene in papillary serous carcinoma of the peritoneum.

  Schorge JO, Miller YB, Qi LJ, Muto MG, Welch WR, Berkowitz RS, Mok SC. Schorge JO, et al. Gynecol Oncol. 2000 Mar;76(3):369-72. doi: 10.1006/gyno.1999.5711. Gynecol Oncol. 2000. PMID: 10684712
• The lack of clinical value of peritoneal washing cytology in high risk patients undergoing risk-reducing salpingo-oophorectomy: a retrospective study and review.

  Blok F, Roes EM, van Leenders GJ, van Beekhuizen HJ. Blok F, et al. BMC Cancer. 2016 Jan 14;16:18. doi: 10.1186/s12885-015-2011-5. BMC Cancer. 2016. PMID: 26768420 Free PMC article. Review.